Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 327 followers
Latest posts
Last updated 2 days ago
CRO Sygnature Discovery plans to send 60 UK staffers packing
2 days ago
British drug discoverer Sygnature Discovery plans to lay off 60 employees in...
Inside Henlius’ global growth strategy
2 days ago
Henlius CEO Jason Zhu shares how the biotech balances biosimilars, innovation and...
Corcept submitted lead asset for approval despite FDA flagging risk of ‘significant review issues'
2 days ago
The FDA warned Corcept Therapeutics that it would face significant hurdles if...
Chugai drops only AI-assisted antibody from pipeline, but still holds high hopes for tech
3 days ago
Chugai Pharmaceutical has dropped its only clinical candidate that was developed with...
Moderna's latest CMO steps down after barely a year
3 days ago
Moderna’s Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a...
Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
3 days ago
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from...
Chutes & Ladders—Cardiff churns C-suite to advance cancer candidate
3 days ago
Cardiff is churning its leadership team as the biotech advances its colorectal...
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
3 days ago
Moderna has outlicensed a rare disease drug candidate to Recordati, accepting $50...
AstraZeneca returns to China’s CSPC for $4.7B obesity deal
3 days ago
The ink was barely dry on AstraZeneca’s announcement of a landmark investment...
How Mirum is Advancing Rare Disease Care Through Strategic M&A
3 days ago
Mirum Pharmaceuticals is applying a disciplined rare disease strategy to build a...
Formation Bio’s China shopping spree continues with $500M biobucks autoimmune pact
3 days ago
AI-fueled Formation Bio has inked another licensing deal for a China asset...
Belgium biotech Agomab outlines up to $212M Nasdaq debut to fund immunology trials
4 days ago
Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million...